|
|
Volumn 390, Issue 10099, 2017, Pages 1006-
|
|
CAR T-cells: an exciting frontier in cancer therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD19 ANTIGEN;
CHIMERIC ANTIGEN RECEPTOR;
INTERLEUKIN 6;
TISAGENLECLEUCEL T;
TOCILIZUMAB;
LYMPHOCYTE ANTIGEN RECEPTOR;
CANCER CHEMOTHERAPY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PEDIATRIC SURGERY;
PRIORITY JOURNAL;
ADOLESCENT;
B CELL LEUKEMIA;
BIOLOGICAL THERAPY;
CHILD;
GENETICS;
INFANT;
METABOLISM;
PRESCHOOL CHILD;
YOUNG ADULT;
ADOLESCENT;
CELL- AND TISSUE-BASED THERAPY;
CHILD;
CHILD, PRESCHOOL;
HUMANS;
INFANT;
LEUKEMIA, B-CELL;
RECEPTORS, ANTIGEN, T-CELL;
YOUNG ADULT;
|
|
EID: 85032927440
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(17)32395-4 Document Type: Editorial |
|
Times cited : (15)
|
|
References (0)
|